USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Ottobock SE & Co. Kgaa

USPTO PatentsView assignee record - 119 granted patents across 32 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Ottobock ranks #3,160 of 49,997 tracked US assignees by granted-patent volume, with 119 patents across 32 technology areas.

#3,160
of 49,997 US assignees by volume
Top 10%
by Innovation Score (52.3/100)
16.2
avg claims per patent
+418%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3160 · Foreign Corporation #3,160 · 119 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MID 119 grants
  • TOP-DECILE #3,160/49,997
  • PHOTO-FINISH Driscoll's
  • CPC-FOCUS A61F · 32 areas
  • INNOV-PAR 52.3/100
  • CLAIMS-RICH 16.2 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +418% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Driscoll's, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Ottobock

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Ottobock's Innovation Score is 52.3/100 (top 10% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Ottobock's grants concentrate

Ottobock SE & Co. Kgaa is a focused PatentsView assignee: 32 CPC subclasses with 81.5% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2020 (22 grants) versus a trough of 14 in 2022. By volume, Ottobock sits between Driscoll's, Inc. and Swisscom AG.

Ottobock's three-year grant acceleration

From 2019–2021 to 2022–2024, Ottobock SE & Co. Kgaa moved from 55 to 50 grants (0.91x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,445. See the growth leaderboard.

Who files at Ottobock's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Ottobock holds 119 patents at rank #3,160, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Ottobock

By rank, the assignees closest to #3,160 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Ottobock's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Ottobock, neither rank-band nor same-CPC leaders (those blocks stay above).

Ottobock's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

52 Top 10% higher than 90% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

12141618202224 2019202020212022202320242025 14
USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Ottobock SE & Co. Kgaa patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 17 14.3%
2020 22 18.5%
2021 16 13.4%
2022 14 11.8%
2023 18 15.1%
2024 18 15.1%
2025partial year 14 11.8%

Which technologies does Ottobock SE & Co. Kgaa patent most?

Top 15 of 32 technology areas

Where it ranks

Overall rank by patents

#3,160

of 49,997 tracked assignees

Innovation Score

52.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Ottobock SE & Co. Kgaa's patent record in context - here's where to go next.

  • Ottobock SE & Co. Kgaa's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 81.5% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #3,160 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Ottobock SE & Co. Kgaa against Driscoll's, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 52.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.